Advertisement

BioPlus Acquisition Corp. BIOS

Set alert

Price alert · BIOS

All alert types
10.80 +10.80 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
209.07M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Short ratio
0.11
Inst. own
167.01%
Dividend
0.00
Ex-div date
Earnings
Mar 20, 2020
50-d avg
10.77
200-d avg
10.55
1y target
20.00

2Y chart

Chart tools
Interval

Signals (79)
NameDateAgo
MACD: Sell SignalSep 29, 20233 years ago
MACD: Buy SignalSep 25, 20233 years ago
MACD: Sell SignalSep 20, 20233 years ago
MACD: Buy SignalSep 19, 20233 years ago
MACD: Sell SignalSep 14, 20233 years ago
RSI: OverboughtSep 12, 20233 years ago
RSI: OverboughtSep 7, 20233 years ago
RSI: OverboughtAug 31, 20233 years ago
MACD: Buy SignalAug 29, 20233 years ago
MACD: Sell SignalAug 7, 20233 years ago
MACD: Buy SignalJul 24, 20233 years ago
MACD: Sell SignalJul 11, 20233 years ago
MACD: Buy SignalJun 29, 20233 years ago
MACD: Sell SignalJun 14, 20233 years ago
RSI: OverboughtJun 5, 20233 years ago
RSI: OverboughtMay 31, 20233 years ago
RSI: OverboughtMay 26, 20233 years ago
RSI: OverboughtMay 23, 20233 years ago
MACD: Buy SignalMay 15, 20233 years ago
RSI: OverboughtMay 15, 20233 years ago
MACD: Sell SignalMay 12, 20233 years ago
MACD: Buy SignalMay 2, 20233 years ago
RSI: OverboughtMay 2, 20233 years ago
MACD: Sell SignalMay 1, 20233 years ago
MACD: Buy SignalApr 27, 20233 years ago
RSI: OverboughtApr 27, 20233 years ago
RSI: OverboughtApr 19, 20233 years ago
MACD: Sell SignalApr 10, 20233 years ago
MACD: Buy SignalApr 6, 20233 years ago
RSI: OverboughtMar 30, 20233 years ago
RSI: OverboughtMar 27, 20233 years ago
RSI: OverboughtMar 21, 20233 years ago
RSI: OverboughtMar 15, 20233 years ago
MACD: Sell SignalMar 10, 20233 years ago
MACD: Buy SignalMar 2, 20233 years ago
MACD: Sell SignalFeb 21, 20233 years ago
MACD: Buy SignalFeb 10, 20233 years ago
MACD: Sell SignalJan 23, 20233 years ago
MACD: Buy SignalJan 3, 20233 years ago
RSI: OverboughtJan 3, 20233 years ago
MACD: Sell SignalDec 20, 20223 years ago
RSI: OverboughtDec 19, 20223 years ago
MACD: Buy SignalDec 13, 20223 years ago
RSI: OverboughtDec 8, 20223 years ago
RSI: OverboughtNov 30, 20223 years ago
MACD: Sell SignalNov 23, 20223 years ago
MACD: Buy SignalNov 16, 20223 years ago
RSI: OverboughtNov 15, 20223 years ago
MACD: Sell SignalNov 10, 20223 years ago
RSI: OverboughtOct 25, 20224 years ago
RSI: OverboughtOct 19, 20224 years ago
MACD: Buy SignalOct 18, 20224 years ago
MACD: Sell SignalOct 13, 20224 years ago
MACD: Buy SignalOct 3, 20224 years ago
MACD: Sell SignalSep 7, 20224 years ago
MACD: Buy SignalSep 1, 20224 years ago
MACD: Sell SignalAug 30, 20224 years ago
MACD: Buy SignalAug 23, 20224 years ago
RSI: OverboughtAug 23, 20224 years ago
MACD: Sell SignalAug 18, 20224 years ago
MACD: Buy SignalJul 19, 20224 years ago
MACD: Sell SignalJul 14, 20224 years ago
MACD: Buy SignalJul 7, 20224 years ago
MACD: Sell SignalJul 5, 20224 years ago
MACD: Buy SignalJun 30, 20224 years ago
MACD: Sell SignalJun 27, 20224 years ago
SMA: BullishJun 13, 20224 years ago
SMA: BearishJun 10, 20224 years ago
SMA: BullishJun 9, 20224 years ago
MACD: Buy SignalJun 9, 20224 years ago
SMA: BearishJun 8, 20224 years ago
SMA: BullishJun 3, 20224 years ago
SMA: BearishMay 26, 20224 years ago
MACD: Sell SignalMay 5, 20224 years ago
MACD: Buy SignalMay 3, 20224 years ago
MACD: Sell SignalMay 2, 20224 years ago
RSI: OverboughtApr 19, 20224 years ago
MACD: Buy SignalApr 8, 20224 years ago
MACD: Sell SignalMar 31, 20224 years ago

Key statistics

Market cap
209.07M
Enterprise value
215.74M
Trailing P/E
51.40
Forward P/E
0.00
PEG ratio
-7.93
Price / sales
0.00
Price / book
0.00
EPS (TTM)
0.21
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-958.04K
Total cash
2.45K
Total debt
6.57M
Return on equity
0.00%
Shares outstanding
19.37M
Short % of float
0.01%
50-day average
10.77
200-day average
10.55

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 20.00 +85.3% upside
Target (low)
16.00
Target (mean)
20.00
Target (high)
23.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Mar 20, 2020

Expected Mar 20, 2020. Consensus EPS estimate -0.09.

Earnings history

Financials — quick view

All financials
BIOS Revenue — quarterly 0
2021-Q2 20212021-Q3 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
BIOS Net income — quarterly 1.24M
2021-Q2 20212021-Q3 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023
BIOS EPS — quarterly 0.05
2021-Q2 20212021-Q3 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 2023

Earnings

BIOS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Mar 20, 2020Dec 1, 2019-0.01———
Nov 6, 2019Sep 1, 2019-0.01———
Jul 30, 2019Jun 1, 2019-0.10———
May 2, 2019Mar 1, 2019-0.12———
Mar 15, 2019Dec 1, 2018-0.03———
Nov 6, 2018Sep 1, 2018-0.07———

About BioPlus Acquisition Corp.

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Sector
Financial Services
Industry
Shell Companies
Country
United States

News

Your note

Sign in to keep a note on BIOS — it syncs with the Stock Master app.

Insider holders

BIOS insider holders
InsiderRelationLatest transactionDateShares held
BIOPLUS SPONSOR ,LLCBeneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 4, 20230

Institution ownership

BIOS institution ownership
Holder% heldSharesValueReported
Westchester Capital Management, LLC10.21%1,390,00014.80MJun 29, 2023
First Trust Capital Management L.P.8.12%1,106,37811.78MJun 29, 2023
Mizuho Securities USA LLC7.45%1,014,33410.80MJun 29, 2023
Linden Advisors LP7.34%1,000,00010.65MJun 29, 2023
Radcliffe Capital Management, L.P.5.28%718,7477.65MJun 29, 2023
Berkley W R Corp4.39%597,6316.36MJun 29, 2023

Fund ownership

BIOS fund ownership
Holder% heldSharesValueReported
Merger Fund, The8.22%1,119,97611.93MJun 29, 2023
Investment Managers Ser Tr II-First Trust Merger Arbitrage Fd7.76%1,056,37811.25MJun 29, 2023
WCM Alternatives Event Driven Fd0.59%80,049852.52KJun 29, 2023
Saba Capital Income & Opportunities Fd0.58%78,809843.26KJul 30, 2023
JNL Series Trust-JNL/Multi Manager Alternative Fund0.57%77,112821.24KJun 29, 2023
Merger Fund Vl, The0.29%39,856424.47KJun 29, 2023
Advertisement